Oncology Research Professor of Thyroid Cancer
Professor of Internal Medicine
[email protected]
Available to mentor
Francis P Worden
Clinical Professor
-
Center MemberRogel Cancer Center
-
Ceylanoglu KS, Eisenberg A, Worden FP, Elner VM, Demirci H. Cornea, 2024 Apr 1; 43 (4): 528 - 530.Journal ArticleUse of Cemiplimab, an Immune Checkpoint Inhibitor for Conjunctival Intraepithelial Neoplasia.
DOI:10.1097/ICO.0000000000003452 PMID: 38166243 -
Swiecicki PL, Bellile E, Dragovic AF, McHugh J, Udager A, Mierzwa ML, Shah J, Heft Neal M, Rosko A, Malloy KM, Casper K, Chinn SB, Shuman AG, Stucken C, Chepeha DB, Wolf GT, Bradford CR, Eisbruch A, Prince MEP, Worden FP, Spector ME. Clin Cancer Res, 2024 Mar 22;Journal ArticleUpfront neck dissection for treatment selection and improvement in quality of life as a novel treatment paradigm for deintensification in HPV+ OPSCC.
DOI:10.1158/1078-0432.CCR-23-3247 PMID: 38517480 -
Gianoukakis AG, Choe JH, Bowles DW, Brose MS, Wirth LJ, Owonikoko T, Babajanyan S, Worden FP. Eur Thyroid J, 2024 Feb 1; 13 (1):Journal ArticleReal-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer.
DOI:10.1530/ETJ-23-0039 PMID: 38096102 -
De Braud F, Deschler-Baier B, Morris JC, Worden F, Han Y, Kiiskinen U, Jen M-H, Barker SS, Szymczak S, Gilligan AM. Cancers (Basel), 2023 Dec 27; 16 (1):Journal ArticleComparative Effectiveness of First-Line Selpercatinib versus Standard Therapies in Patients with RET-Activated Cancers: An Exploratory Interpatient Analysis of LIBRETTO-001.
DOI:10.3390/cancers16010140 PMID: 38201566 -
Singalavanija T, Ceylanoglu KS, Juntipwong S, Beser BG, Elner VM, Worden FP, Demirci H. Ophthalmic Plast Reconstr Surg, 2024 Jan; 40 (1): 1 - 10.Journal ArticleReview of Targeted Therapy, Vismodegib, for the Treatment of Periocular Basal Cell Carcinoma.
DOI:10.1097/IOP.0000000000002464 PMID: 37552493 -
Serbest Ceylanoglu K, Guneri Beser B, Singalavanija T, Juntipwong S, Worden FP, Demirci H. Ophthalmic Plast Reconstr Surg, 2024 Jan; 40 (1): 18 - 29.Journal ArticleTargeted Therapy and Immunotherapy for Advanced Malignant Conjunctival Tumors: Systematic Review.
DOI:10.1097/IOP.0000000000002488 PMID: 38241616 -
Michniacki T, Walkovich K. 2024 Hematology Board Review: Blueprint Study Guide and Q&A,ChapterWhite Blood Cell Disorders
-
Kropp E, Jones M. 2023 Dec 26; Hematology Board Review Blueprint Study Guide and Q&A,ChapterChapter 1. Stem Cell Biology and Hematopoeisis